MetGen (private company)

See something wrong or missing? Let us know
Offices:Kaarina
Industry:Biotech
Business model:B2B

MetGen develops and produces enzymes tailored to industrial customer needs. MetZymes are enzymes belonging to the class of multicopper oxidases.

These enzymes are involved in several oxidative functions and particularly in delignification.

Investors: we tracked 6 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 2.95M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to MetGen

Name Criteria
Finland Tenboron
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one other investor: Finnvera
  • Total raised in a similar range: 1M - 5M USD
Denmark AFYX Therapeutics
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sofinnova Partners
Denmark Biosyntia
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sofinnova Partners
Sweden EnginZyme
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sofinnova Partners
Switzerland Noema Pharma
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sofinnova Partners
Finland Akkurate
38%
  • Similar business models: B2B
  • At least one vc investor: Tesi
  • Total raised in a similar range: 1M - 5M USD
Finland Disior
38%
  • Similar business models: B2B
  • At least one vc investor: Tesi
  • Total raised in a similar range: 1M - 5M USD
Finland Endev
38%
  • Similar business models: B2B
  • At least one vc investor: Tesi
  • Total raised in a similar range: 1M - 5M USD
Finland Mekitec
38%
  • Similar business models: B2B
  • At least one vc investor: Tesi
  • Total raised in a similar range: 1M - 5M USD
Finland Glucostratus (Mendor)
38%
  • Similar business models: B2B
  • At least one vc investor: Tesi
  • At least one other investor: Finnvera
Top